{"id":"W4414913305","doi":"10.3390/biomedicines13102442","title":"Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells","year":2025,"lang":"en","type":"article","venue":"Biomedicines","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"NAEJA-RGM Pharmaceuticals (Canada)","funders":"National Cancer Institute; Geriatric Research Education and Clinical Center; NIH Clinical Center; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Ixazomib; Prostate cancer; Proteasome inhibitor; Programmed cell death; Cancer cell; Syngenic; Apoptosis; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001890021,0.0005931682,0.0005438898,0.0002735984,0.000106219,0.00003554494,0.0003148034,0.000220349,0.00001429543],"category_scores_gemma":[0.00006025251,0.0004230228,0.00007736283,0.0005841552,0.0002763144,0.00001621782,0.0001215508,0.0002311079,0.000006427799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000126104,"about_ca_system_score_gemma":0.0007967491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002512874,"about_ca_topic_score_gemma":0.0001829166,"domain_scores_codex":[0.9973636,0.0001272712,0.0004473484,0.001022844,0.0004107791,0.0006281029],"domain_scores_gemma":[0.9986254,0.00007978743,0.0002571435,0.0005891106,0.0001990399,0.0002495398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01051639,0.0006605045,0.02414939,0.001087988,0.00008520581,0.0001108934,0.0001141041,0.0002269198,0.960215,0.000001293311,0.001851997,0.0009802643],"study_design_scores_gemma":[0.008913073,0.004910081,0.005512777,0.002949768,0.00009964118,0.000001948786,0.0000842696,0.00004344097,0.9758269,0.00001425846,0.001107104,0.0005367461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929372,0.001490999,0.00003259806,0.0003487541,0.0004608051,0.004350702,0.0001806127,0.00005455171,0.0001437979],"genre_scores_gemma":[0.9927448,0.0002340221,0.0009489958,0.0005861153,0.0005160336,0.003738775,0.0001150113,0.00008304088,0.001033183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01863661,"threshold_uncertainty_score":0.9998221,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004092825607968657,"score_gpt":0.2400514327997586,"score_spread":0.23595860719179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}